Literature DB >> 1714379

Interference and synergism of glucocorticoid receptor and octamer factors.

S Wieland1, U Döbbeling, S Rusconi.   

Abstract

We have analysed the interplay of glucocorticoid receptor (GR) and the lymphocyte-specific factor Oct-2A with transient co-transfection assays. Our data confirm our previously described observation that GR and the apparently unrelated factors belonging to the Octamer family can synergize when permitted to bind in cis. However, when GR binding sites are not present in the reporter genes, we observe that the action of the cloned factor Oct-2A expressed in HeLa cells is strongly inhibited in the presence of active GR molecules. We can demonstrate that this GR-mediated inhibition of Oct-2A action is neither due to competitive binding to DNA target sites nor to a reduction of DNA binding competent Oct-2A in the transfected cells. We observe that the phenomenon is not reciprocal, since co-expression of Oct-2A does not inhibit GR-dependent transcription activation. Furthermore, we provide evidence that the observed GR-Oct-2A interference may be dependent on the type of cell line hosting the co-transfected molecules. We consider it likely that the GR-mediated inhibition is due to the exhaustion of some rate-limiting co-activators.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714379      PMCID: PMC452948          DOI: 10.1002/j.1460-2075.1991.tb07791.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  58 in total

1.  The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16.

Authors:  S Stern; M Tanaka; W Herr
Journal:  Nature       Date:  1989-10-19       Impact factor: 49.962

Review 2.  Enhancer sequences and the regulation of gene transcription.

Authors:  M M Müller; T Gerster; W Schaffner
Journal:  Eur J Biochem       Date:  1988-10-01

Review 3.  How eukaryotic transcriptional activators work.

Authors:  M Ptashne
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

4.  Deletion analysis of GAL4 defines two transcriptional activating segments.

Authors:  J Ma; M Ptashne
Journal:  Cell       Date:  1987-03-13       Impact factor: 41.582

5.  The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain.

Authors:  L P Freedman; B F Luisi; Z R Korszun; R Basavappa; P B Sigler; K R Yamamoto
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

6.  Transcriptional inhibition by a glucocorticoid receptor-beta-galactosidase fusion protein.

Authors:  A E Oro; S M Hollenberg; R M Evans
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

7.  Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif.

Authors:  A J Courey; R Tjian
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

8.  Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA).

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

9.  Cell type-specificity elements of the immunoglobulin heavy chain gene enhancer.

Authors:  T Gerster; P Matthias; M Thali; J Jiricny; W Schaffner
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

10.  Functional dissection of the hormone and DNA binding activities of the glucocorticoid receptor.

Authors:  S Rusconi; K R Yamamoto
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

View more
  18 in total

1.  Recruitment of octamer transcription factors to DNA by glucocorticoid receptor.

Authors:  G G Préfontaine; M E Lemieux; W Giffin; C Schild-Poulter; L Pope; E LaCasse; P Walker; R J Haché
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

2.  Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription.

Authors:  E Stoecklin; M Wissler; R Moriggl; B Groner
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  The influence of IL-7 V(D)J recombination.

Authors:  U Döbbeling
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

4.  Involvement of a C/EBP-like protein in the acquisition of responsiveness to glucocorticoid hormones during chick neural retina development.

Authors:  S Ben-Or; S Okret
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

5.  Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1.

Authors:  E Kutoh; P E Strömstedt; L Poellinger
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

6.  Constitutive repression and nuclear factor I-dependent hormone activation of the mouse mammary tumor virus promoter in Saccharomyces cerevisiae.

Authors:  S Chávez; R Candau; M Truss; M Beato
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

7.  An octamer motif contributes to the expression of the retinoic acid-regulated zinc finger gene Rex-1 (Zfp-42) in F9 teratocarcinoma cells.

Authors:  B A Hosler; M B Rogers; C A Kozak; L J Gudas
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

8.  Glucocorticoids induce human glycoprotein hormone alpha-subunit gene expression in the gonadotrope.

Authors:  Ravid Sasson; Sang H Luu; Varykina G Thackray; Pamela L Mellon
Journal:  Endocrinology       Date:  2008-04-10       Impact factor: 4.736

9.  Mapping of a major surface-exposed site in herpes simplex virus protein Vmw65 to a region of direct interaction in a transcription complex assembly.

Authors:  S Hayes; P O'Hare
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Retinoic acid repression of cell-specific helix-loop-helix-octamer activation of the calcitonin/calcitonin gene-related peptide enhancer.

Authors:  T M Lanigan; L A Tverberg; A F Russo
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.